ASX:AVH - Avita Medical Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
A$0.47 -0.01 (-2.08 %)
(As of 05/24/2019 04:00 PM ET)
Previous CloseA$0.47
Today's RangeA$0.47 - A$0.48
52-Week RangeA$0.05 - A$0.54
Volume2.47 million shs
Average VolumeN/A
Market Capitalization$876.81 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Avita Medical Limited operates as a regenerative medicine company in the Asia Pacific, Europe, the Middle East, Africa, and the Americas. It offers regenerative products for the treatment of burns, chronic wounds, and aesthetics indications. The company's patented and proprietary collection and application technology provides treatment solutions derived from a patient's own skin. Its lead product, RECELL System, is used in the treatment of various skin defects, such as burns and plastic reconstructive procedures. The company also offers ReGenerCell for chronic wounds and ReNovaCell for the restoration of pigmentation. Avita Medical Limited is based in Valencia, California.

Receive AVH News and Ratings via Email

Sign-up to receive the latest news and ratings for AVH and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Devices
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone661-367-9170

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.86 million
Cash FlowA$0.02 per share
Book ValueA$0.02 per share

Profitability

Miscellaneous

Employees55
Outstanding Shares1,865,549,952
Market Cap$876.81 million
Next Earnings DateN/A
OptionableOptionable

Avita Medical (ASX:AVH) Frequently Asked Questions

What is Avita Medical's stock symbol?

Avita Medical trades on the ASX under the ticker symbol "AVH."

Has Avita Medical been receiving favorable news coverage?

News articles about AVH stock have trended positive recently, InfoTrie reports. The research firm identifies positive and negative media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Avita Medical earned a news sentiment score of 3.0 on InfoTrie's scale. They also gave headlines about the company a news buzz of 4.0 out of 10, indicating that recent media coverage is somewhat unlikely to have an impact on the company's share price in the near future.

Who are some of Avita Medical's key competitors?

What other stocks do shareholders of Avita Medical own?

Who are Avita Medical's key executives?

Avita Medical's management team includes the folowing people:
  • Dr. Michael S. Perry, CEO & Director (Age 60)
  • Mr. Dale A. Sander, Chief Financial Officer (Age 59)
  • Mr. Timothy Rooney, Chief Admin. Officer
  • Mr. Andrew Quick, Sr. VP of Clinical Devel.
  • Ms. Erin Liberto, Chief Commercial Officer

What is Avita Medical's stock price today?

One share of AVH stock can currently be purchased for approximately A$0.47.

How big of a company is Avita Medical?

Avita Medical has a market capitalization of $876.81 million and generates $2.86 million in revenue each year. Avita Medical employs 55 workers across the globe.

What is Avita Medical's official website?

The official website for Avita Medical is http://www.avitamedical.com/.

How can I contact Avita Medical?

The company can be reached via phone at 661-367-9170.


MarketBeat Community Rating for Avita Medical (ASX AVH)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  2 (Vote Outperform)
Underperform Votes:  3 (Vote Underperform)
Total Votes:  5
MarketBeat's community ratings are surveys of what our community members think about Avita Medical and other stocks. Vote "Outperform" if you believe AVH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AVH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 5/25/2019 by MarketBeat.com Staff

Featured Article: What is the Current Ratio?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel